Moreover, it has been shown that a small proportion of CRPC tumour cells acquire a neuroendocrine phenotype with neuronal marker expression, including chromogranin A (CHGA), synaptophysin (SYP) or enolase-2 (ENO2) [7, 8]. This evidence concerns the gene ENO2 and neoplasm.